Amos Katz

Amos Katz

Ben Gurion University of the Negev - Beer Sheva / Israel
Medical and Health Sciences / Cardiology
AD Scientific Index ID: 301876
אוניברסיטת בן גוריון בנגב
person_outline Amos Katz's MOST POPULAR ARTICLES
1-) Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trialSS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ...The Lancet 391 (10117), 219-229, 20187532018
2-) Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trialG Hindricks, M Taborsky, M Glikson, U Heinrich, B Schumacher, A Katz, ...The Lancet 384 (9943), 583-590, 20147162014
3-) Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialI Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, ...The Lancet 396 (10253), 759-769, 20207322020
4-) J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significanceR Rosso, E Kogan, B Belhassen, U Rozovski, MM Scheinman, D Zeltser, ...Journal of the American College of Cardiology 52 (15), 1231-1238, 20087392008
5-) Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb studyJR Teerlink, M Metra, GM Felker, P Ponikowski, AA Voors, BD Weatherley, ...The Lancet 373 (9673), 1429-1439, 20095212009